RU98118763A - METHOD FOR TREATING PRIMARY ARTERIAL HYPERTENSION - Google Patents

METHOD FOR TREATING PRIMARY ARTERIAL HYPERTENSION

Info

Publication number
RU98118763A
RU98118763A RU98118763/14A RU98118763A RU98118763A RU 98118763 A RU98118763 A RU 98118763A RU 98118763/14 A RU98118763/14 A RU 98118763/14A RU 98118763 A RU98118763 A RU 98118763A RU 98118763 A RU98118763 A RU 98118763A
Authority
RU
Russia
Prior art keywords
arterial hypertension
treating primary
primary arterial
antioxidant
courses
Prior art date
Application number
RU98118763/14A
Other languages
Russian (ru)
Other versions
RU2164410C2 (en
Inventor
Е.Г. Гольдина
И.Р. Гайсин
Л.А. Лещинский
И.В. Логачева
Р.М. Валеева
Е.Н. Зайцева
Е.В. Ивашкина
Е.М. Бушмакина
Original Assignee
Ижевская государственная медицинская академия
Filing date
Publication date
Application filed by Ижевская государственная медицинская академия filed Critical Ижевская государственная медицинская академия
Priority to RU98118763A priority Critical patent/RU2164410C2/en
Priority claimed from RU98118763A external-priority patent/RU2164410C2/en
Publication of RU98118763A publication Critical patent/RU98118763A/en
Application granted granted Critical
Publication of RU2164410C2 publication Critical patent/RU2164410C2/en

Links

Claims (2)

1. Способ лечения первичной артериальной гипертензии, включающий применение ингибитора ангиотензинпревращающего фермента, отличающийся тем, что дополнительно применяют антиоксидант, при этом прием антиоксиданта производят на фоне постоянного приема ингибитора ангиотензинпревращающего фермента в три курса продолжительностью по месяцу и с промежутком между курсами в 4-5 месяцев.1. A method of treating primary arterial hypertension, including the use of an angiotensin converting enzyme inhibitor, characterized in that the antioxidant is additionally used, while the antioxidant is taken against a background of continuous administration of an angiotensin converting enzyme inhibitor in three courses lasting a month and with an interval between courses of 4-5 months . 2. Способ по п.1, отличающийся тем, что в качестве антиоксиданта применяют α-токоферола ацетат. 2. The method according to claim 1, characterized in that α-tocopherol acetate is used as an antioxidant.
RU98118763A 1998-10-08 1998-10-08 Method of treatment of patients with essential hypertension RU2164410C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU98118763A RU2164410C2 (en) 1998-10-08 1998-10-08 Method of treatment of patients with essential hypertension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU98118763A RU2164410C2 (en) 1998-10-08 1998-10-08 Method of treatment of patients with essential hypertension

Publications (2)

Publication Number Publication Date
RU98118763A true RU98118763A (en) 2000-07-20
RU2164410C2 RU2164410C2 (en) 2001-03-27

Family

ID=20211305

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98118763A RU2164410C2 (en) 1998-10-08 1998-10-08 Method of treatment of patients with essential hypertension

Country Status (1)

Country Link
RU (1) RU2164410C2 (en)

Similar Documents

Publication Publication Date Title
TR200103493T2 (en) Metalloprotease inhibitors
DE69927805D1 (en) NEW FAT ANALOGUE FOR THE TREATMENT OF SECONDARY RESTENOSIS
LU91758I2 (en) Denosumab and its pharmaceutically acceptable derivatives (PROLIA®)
TR199802296T2 (en) New 2,3 disubstituted-4 (3H)-quinazolinones
BR9811099A (en) Urokinase inhibitors
CA2130577A1 (en) Combinations of ace inhibitors and diuretics
BG103096A (en) Thrombin inhibitors
SE9303691D0 (en) New beverage
RU2001109436A (en) COSMETIC COMPOSITION
DK1032414T3 (en) Combination of angiotensin converting enzyme inhibitor with a diuretic for the treatment of microcirculatory disorders
FI973691A (en) Compositions comprising amlodipine or a salt thereof or felodipine and an ACE inhibitor
NO980221L (en) Procedure for the treatment of colon adenomas
EP3078386A3 (en) Method of treatment and bioassay involving macrophage migration inhibitory factor (mif) as cardiac-derived myocardial depressant factor
RU98118763A (en) METHOD FOR TREATING PRIMARY ARTERIAL HYPERTENSION
NO20003758L (en) wood preservatives
ATE321045T1 (en) METHODS AND COMPOSITIONS FOR TREATING PAIN
WO2001076593A3 (en) Bile secretion promoting composition a 15-keto prostaglandin
DE69727583D1 (en) PREVENTION OF GASTROINTESTINAL DAMAGE
DE3466396D1 (en) A retro-inverso analogue of the (5-14) decapeptide of equine angiotensinogen, as a specific renin inhibitor with high resistance to enzymatic hydrolysis
NO982112D0 (en) Fixed-dose composition of an angiotensin-converting enzyme inhibitor and a calcium channel antagonist, method for its preparation and its use in the treatment of cardiovascular diseases
ATE302026T1 (en) COMPOSITION CONTAINING AN INHIBITOR OF SIGNAL TRANSDUCTION OF HETEROMETRIC G PROTEINS IN COMBINATION WITH AN ANTIHYPERTENSIVE AGENT FOR THERAPEUTIC USE IN THE TREATMENT OF ARTERIAL HYPERTENSION
FR2369845A1 (en) Excessive tobacco consumption treatment compsn. - contains capsicum, aconite, ballota, crataegus, drosera, grindelia, lobelia, passion flower and white willow
NZ336362A (en) Use of a 15-keto-prostaglandin compound as a portal hypertension inhibitor
DE69721077D1 (en) USE OF 2-METHOXYPHENYL-1-METHYL-5P-METHYL-BENZOYLPYRROL-2-ACETAMIDO ACETATE FOR THE PRODUCTION OF AN ANTI-IGNITANT WITH PREVENTING STOMACH HYPERSECRETION AND KIDNEY Dysfunction
RU99101266A (en) METHOD FOR TREATING PRIMARY ARTERIAL HYPERTENSION